These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Topical calcipotriol for preventive treatment of hypertrophic scars: a randomized, double-blind, placebo-controlled trial. van der Veer WM; Jacobs XE; Waardenburg IE; Ulrich MM; Niessen FB Arch Dermatol; 2009 Nov; 145(11):1269-75. PubMed ID: 19917956 [TBL] [Abstract][Full Text] [Related]
44. Comparison of Steroid and Botulinum Toxin Type A Monotherapy with Combination Therapy for Treating Human Hypertrophic Scars in an Animal Model. Chen HC; Yen CI; Yang SY; Chang CJ; Yang JY; Chang SY; Chuang SS; Hsiao YC Plast Reconstr Surg; 2017 Jul; 140(1):43e-49e. PubMed ID: 28654594 [TBL] [Abstract][Full Text] [Related]
45. Treatment of facial wounds with botulinum toxin A improves cosmetic outcome in primates. Gassner HG; Sherris DA; Otley CC Plast Reconstr Surg; 2000 May; 105(6):1948-53; discussion 1954-5. PubMed ID: 10839391 [TBL] [Abstract][Full Text] [Related]
46. Effectiveness of Botulinum Toxin Type A Injection on Scars: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Li MY; Chiu WK; Wang HJ; Chen IF; Chen JH; Chang TP; Ko Y; Chen C Plast Reconstr Surg; 2022 Dec; 150(6):1249e-1258e. PubMed ID: 36112846 [TBL] [Abstract][Full Text] [Related]
47. Efficacy and safety of thermomechanical fractional injury-assisted corticosteroid delivery versus intralesional corticosteroid injection for the treatment of hypertrophic scars: A randomized split-scar trial. Manuskiatti W; Yan C; Artzi O; Gervasio MKR; Wanitphakdeedecha R Lasers Surg Med; 2022 Apr; 54(4):483-489. PubMed ID: 34913497 [TBL] [Abstract][Full Text] [Related]
48. Treatment of major depressive disorder using botulinum toxin A: a 24-week randomized, double-blind, placebo-controlled study. Magid M; Reichenberg JS; Poth PE; Robertson HT; LaViolette AK; Kruger TH; Wollmer MA J Clin Psychiatry; 2014 Aug; 75(8):837-44. PubMed ID: 24910934 [TBL] [Abstract][Full Text] [Related]
49. Botulinum toxin type B for cervical dystonia. Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C Cochrane Database Syst Rev; 2005 Jan; (1):CD004315. PubMed ID: 15674941 [TBL] [Abstract][Full Text] [Related]
51. The Use of Botulinum Toxin-A as an Adjunctive Treatment for Facial Atrophic and Hypertrophic Scars After Surgical Correction. Samarth A; Budamakuntla L; Shilpa K J Cutan Aesthet Surg; 2022; 15(2):131-134. PubMed ID: 35965916 [TBL] [Abstract][Full Text] [Related]
52. Topical diltiazem cream versus botulinum toxin a for the treatment of chronic anal fissure: a double-blind randomized clinical trial. Samim M; Twigt B; Stoker L; Pronk A Ann Surg; 2012 Jan; 255(1):18-22. PubMed ID: 21685792 [TBL] [Abstract][Full Text] [Related]
53. The Safety and efficacy of botulinum toxin type A injection for postoperative scar prevention: A systematic review and meta-analysis. Yang W; Li G J Cosmet Dermatol; 2020 Apr; 19(4):799-808. PubMed ID: 31513335 [TBL] [Abstract][Full Text] [Related]
54. Effects of Botulinum Toxin on Improving Facial Surgical Scars: A Prospective, Split-Scar, Double-Blind, Randomized Controlled Trial. Dadaci M; Yildirim MEC; İnce B Plast Reconstr Surg; 2019 Jan; 143(1):237e-238e. PubMed ID: 30418318 [No Abstract] [Full Text] [Related]
55. Laser treatments in early wound healing improve scar appearance: a randomized split-wound trial with nonablative fractional laser exposures vs. untreated controls. Karmisholt KE; Banzhaf CA; Glud M; Yeung K; Paasch U; Nast A; Haedersdal M Br J Dermatol; 2018 Dec; 179(6):1307-1314. PubMed ID: 30101519 [TBL] [Abstract][Full Text] [Related]
56. Safety and efficacy of botulinum toxin type A in preventing and treating scars in animal models: A systematic review and meta-analysis. Pan L; Qin H; Li C; Yang L; Li M; Kong J; Zhang G; Zhang L Int Wound J; 2022 May; 19(4):774-781. PubMed ID: 34402205 [TBL] [Abstract][Full Text] [Related]
57. Intraprostatic botulinum toxin type "A" injection in patients with benign prostatic hyperplasia and unsatisfactory response to medical therapy: A randomized, double-blind, controlled trial using urodynamic evaluation. Totaro A; Pinto F; Pugliese D; Vittori M; Racioppi M; Foschi N; Bassi PF; Sacco E Neurourol Urodyn; 2018 Mar; 37(3):1031-1038. PubMed ID: 28840969 [TBL] [Abstract][Full Text] [Related]
58. Reply: Effects of Botulinum Toxin on Improving Facial Surgical Scars: A Prospective, Split-Scar, Double-Blind, Randomized Controlled Trial. Hu L; Chang SJ; Jin Y; Lin X Plast Reconstr Surg; 2019 Jan; 143(1):238e-239e. PubMed ID: 30589819 [No Abstract] [Full Text] [Related]
59. Efficacy and safety of botulinum toxin type A for postoperative scar prevention and wound healing improvement: A systematic review and meta-analysis. Fu Z; Huang H; Huang J J Cosmet Dermatol; 2022 Jan; 21(1):176-190. PubMed ID: 34859567 [TBL] [Abstract][Full Text] [Related]
60. A prospective placebo-controlled study on the efficacy of onion extract in silicone derivative gel for the prevention of hypertrophic scar and keloid in median sternotomy wound in pediatric patients. Wananukul S; Chatpreodprai S; Peongsujarit D; Lertsapcharoen P J Med Assoc Thai; 2013 Nov; 96(11):1428-33. PubMed ID: 24428092 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]